Organisation: Luxembourg Centre for Systems Biomedicine (LCSB)
-
News
World Parkinson’s Day: Sleep survey to gain more knowledge
Learn more11 April marks Parkinson’s Disease Day. Parkinson’s disease (PD) is the second most common neurodegenerative brain disorder, about 7-10 million people are affected worldwide. However, this number is likely to double in the next 20 years due to an ageing population. In Luxembourg, more than 1,000 people with PD are estimated.
-
News
Lasting impact of birth mode on microbiome and immune system
Learn moreIn a recent scientific publication, researchers from the Luxembourg Centre for Systems Biomedicine (LCSB) and the Department of Life Sciences and Medicine at the University of Luxembourg address the knowledge gaps concerning the lasting effect of birth mode on infants. Thanks to a long-standing study – called COSMIC – they highlight differences in the gut…
-
News
Survey on sleep quality to better prevent neurodegenerative diseases
Learn moreThe National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD) launches a nation-wide research survey on sleep behaviour disorders under the patronage of the Ministry of Health. All Luxembourg residents aged between 55 and 75 years will receive a personal invitation letter in subsequent weeks. This survey is part of the second phase of…
-
News
University opens Master of Data Science in September 2021
Learn moreStarting September 2021, the University of Luxembourg will offer a new Master of Data Science. Based on a multidisciplinary approach, the Master’s programme will train students in data analysis, modelling and management, and prepare them to work in areas as artificial intelligence (A.I), cloud computing, machine and statistical learning or big data.
-
News
No cold case – Uni researchers explore the future of forensic genomics
Learn moreSix new interdisciplinary research projects have received multi-year funding in the context of the Audacity funding instrument of the University’s Institute for Advanced Studies.
-
News
Large-scale testing: High transmission risk from asymptomatic carriers
Learn moreBased on the results of the large-scale testing programme run in Luxembourg, researchers show that asymptomatic SARS-CoV-2 carriers represent an important vector for transmission.
-
News
PathoFact identifies pathogens faster and more accurately
Learn moreScientists from the Luxembourg Centre for Systems Biomedicine (LCSB) and the Department of Life Sciences and Medicine of the University of Luxembourg have developed a new bioinformatics tool that can help them identify pathogens much faster and more accurately than was ever possible with conventional diagnostic methods. The team led by Professor Paul Wilmes, head…